Gainers

Spero Therapeutics, Inc. (NASDAQ:SPRO) rose 150% to $2.0508 after the company announced it has entered into an exclusive license agreement with GSK for Spero's late-stage antibiotic asset, tebipenem HBr. Spero Therapeutics will receive $66 million upfront, with potential for future milestone payments, and tiered royalties. HeartBeam, Inc. (NASDAQ:BEAT) shares gained 34% to $2.12 after dropping 16% on Wednesday. Heartbeam recently announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome and cardiac arrhythmia was issued by the USPTO. ShiftPixy, Inc. (NASDAQ:PIXY) shares jumped 32.4% to $18.09. ShiftPixy, on Wednesday, announced pricing of $5 million private placement. Inventiva...